Improving Hypertension Management Through Preference List Defaults
1 other identifier
interventional
12,150
1 country
1
Brief Summary
This study aims to evaluate whether modifying the EPIC preference list to display combination blood pressure (BP) medications at the top and/or adding "(PREFERRED)" to the beginning of the medication listing increases prescribing of these medications. Combination BP medications are aligned with value-based care guidelines and may improve patient adherence and reduce pill burden. Currently, these medications may be under-prescribed in part due to their low visibility in the EPIC prescribing interface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Apr 2026
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2025
CompletedFirst Posted
Study publicly available on registry
December 23, 2025
CompletedStudy Start
First participant enrolled
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
April 28, 2026
April 1, 2026
6 months
December 11, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prescribing of Combination Antihypertensive Medication (y/n)
Defined as whether a provider prescribes a combination blood pressure medication (e.g., a single pill containing two medication classes) on the day of the patient's appointment. This is measured at the patient level using EHR prescribing data.
Day of the appointment (1 day)
Other Outcomes (2)
Change in Systolic Blood Pressure
6 months to 1 year after enrollment (whenever a qualifying reading is taken)
Change in Diastolic Blood Pressure
6 months to 1 year after enrollment (whenever a qualifying reading is taken)
Study Arms (2)
Revised Preference List
EXPERIMENTAL"(PREFERRED)" will be added to the beginning of the preference list for selected BP medications, which will frequently cause these medications to be listed first.
No Change to the Preference List
NO INTERVENTIONClinics will retain the usual EHR preference list order, with no changes to the default medication display.
Interventions
Providers in the intervention group will see "(PREFERRED)" listed before combination blood pressure medication names, which will frequently cause the combination medications to appear at the top of the EHR preference list.
Eligibility Criteria
You may qualify if:
- Order placed for a medication starting with any of the following: "amlodipine", "benazepril", "valsartan", "lisinopril", "hctz", "hydrochlorothiazide", "hydro", "losartan"
- The order is placed at an in-person, virtual (telemed), telephone, or nurse encounter in a clinic included in the study
- Patient is age 18+
- \- Order was placed by a clinical leader who was aware of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Geisinger Cliniclead
Study Sites (1)
Geisinger
Danville, Pennsylvania, 17822, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 11, 2025
First Posted
December 23, 2025
Study Start
April 13, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
April 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share